State of Wisconsin Investment Board’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.39M | Buy |
200,463
+49,921
| +33% | +$385K | ﹤0.01% | 1545 |
|
|
2025
Q4 | $1.33M | Buy |
150,542
+48,149
| +47% | +$265K | ﹤0.01% | 1552 |
|
|
2025
Q3 | $511K | Sell |
102,393
-16,600
| -14% | -$76.8K | ﹤0.01% | 1884 |
|
|
2025
Q2 | $562K | Sell |
118,993
-68,000
| -36% | -$297K | ﹤0.01% | 1808 |
|
|
2025
Q1 | $858K | Buy |
186,993
+20,300
| +12% | +$94.6K | ﹤0.01% | 1538 |
|
|
2024
Q4 | $798K | Sell |
166,693
-7,243
| -4% | -$34.8K | ﹤0.01% | 1613 |
|
|
2024
Q3 | $816K | Buy |
173,936
+74,200
| +74% | +$398K | ﹤0.01% | 1644 |
|
|
2024
Q2 | $564K | Buy |
+99,736
| New | +$515K | ﹤0.01% | 1762 |
|
|
2024
Q1 | – | Sell |
-128,800
| Closed | -$544K | – | 2431 |
|
|
2023
Q4 | $544K | Buy |
128,800
+70,929
| +123% | +$286K | ﹤0.01% | 1689 |
|
|
2023
Q3 | $250K | Sell |
57,871
-32,819
| -36% | -$182K | ﹤0.01% | 2140 |
|
|
2023
Q2 | $598K | Sell |
90,690
-361
| -0.4% | -$2.31K | ﹤0.01% | 1739 |
|
|
2023
Q1 | $618K | Buy |
91,051
+37,790
| +71% | +$266K | ﹤0.01% | 1764 |
|
|
2022
Q4 | $394K | Sell |
53,261
-3,469
| -6% | -$33.8K | ﹤0.01% | 1998 |
|
|
2022
Q3 | $560K | Sell |
56,730
-2,955
| -5% | -$31.2K | ﹤0.01% | 1922 |
|
|
2022
Q2 | $651K | Sell |
59,685
-12,715
| -18% | -$132K | ﹤0.01% | 1936 |
|
|
2022
Q1 | $819K | Hold |
72,400
| – | – | ﹤0.01% | 1682 |
|
|
2021
Q4 | $1.14M | Hold |
72,400
| – | – | ﹤0.01% | 1414 |
|
|
2021
Q3 | $1.24M | Hold |
72,400
| – | – | ﹤0.01% | 1384 |
|
|
2021
Q2 | $1.56M | Hold |
72,400
| – | – | ﹤0.01% | 1341 |
|
|
2021
Q1 | $1.09M | Sell |
72,400
-4,300
| -6% | -$69.6K | ﹤0.01% | 1344 |
|
|
2020
Q4 | $1.01M | Sell |
76,700
-9,500
| -11% | -$114K | ﹤0.01% | 1326 |
|
|
2020
Q3 | $833K | Sell |
86,200
-3,200
| -4% | -$34.2K | ﹤0.01% | 1336 |
|
|
2020
Q2 | $1.02M | Buy |
89,400
+300
| +0.3% | +$3.4K | ﹤0.01% | 1237 |
|
|
2020
Q1 | $923K | Buy |
89,100
+11,000
| +14% | +$136K | ﹤0.01% | 1216 |
|
|
2019
Q4 | $1.28M | Hold |
78,100
| – | – | ﹤0.01% | 1193 |
|
|
2019
Q3 | $1.04M | Buy |
78,100
+3,400
| +5% | +$47.4K | ﹤0.01% | 1132 |
|
|
2019
Q2 | $1.05M | Buy |
74,700
+1,600
| +2% | +$25.5K | ﹤0.01% | 1127 |
|
|
2019
Q1 | $1.34M | Buy |
73,100
+20,400
| +39% | +$465K | ﹤0.01% | 1082 |
|
|
2018
Q4 | $1.38M | Buy |
52,700
+400
| +0.8% | +$9.4K | ﹤0.01% | 1049 |
|
|
2018
Q3 | $1.2M | Hold |
52,300
| – | – | ﹤0.01% | 1151 |
|
|
2018
Q2 | $996K | Buy |
52,300
+19,300
| +58% | +$323K | ﹤0.01% | 1169 |
|
|
2018
Q1 | $556K | Hold |
33,000
| – | – | ﹤0.01% | 1275 |
|
|
2017
Q4 | $502K | Hold |
33,000
| – | – | ﹤0.01% | 1294 |
|
|
2017
Q3 | $591K | Hold |
33,000
| – | – | ﹤0.01% | 1253 |
|
|
2017
Q2 | $538K | Buy |
+33,000
| New | +$476K | ﹤0.01% | 1257 |
|
Other funds holding VNDA
ACM
VCM
State of Wisconsin Investment Board's VNDA Position: Q1 2026 in Review
State of Wisconsin Investment Board increased its Vanda Pharmaceuticals (VNDA) stake by 33% in Q1 2026, buying an estimated $385K and bringing the position to 200,463 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1545.
State of Wisconsin Investment Board first reported a position in VNDA in Q2 2017 and has held it in 35 quarters since. The position peaked at $1.56M in Q2 2021. 171 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.
- State of Wisconsin Investment Board held 200,463 shares of Vanda Pharmaceuticals worth $1.39M as of Q1 2026.
- State of Wisconsin Investment Board bought 49,921 Vanda Pharmaceuticals shares in Q1 2026, an estimated $385K.
- Vanda Pharmaceuticals made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1545 holding.
- State of Wisconsin Investment Board first reported a position in Vanda Pharmaceuticals in Q2 2017 and has held it in 35 quarters since.
- State of Wisconsin Investment Board's Vanda Pharmaceuticals position peaked at $1.56M in Q2 2021.
- 171 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.